
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2014 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2018 | 0 | 5.507.441 | 445.750 | 1 | ||
| 2014 | 0 | 5.999.995 | 70.860 | 1 | ||
Total number of partners: 41
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 41
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2018-06-01 | In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy | SILICOFCM | participant | 5.507.441 | 15 |
| 2014-02-01 | Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies | DISCHARGE | participant | 5.999.995 | 28 |